Company Registration No. 16202851 (England and Wales)
Viridysbio Ltd
Unaudited accounts
for the period from 23 January 2025 to 30 June 2026
Viridysbio Ltd
Unaudited accounts
Contents
Viridysbio Ltd
Company Information
for the period from 23 January 2025 to 30 June 2026
Directors
Dr Rotem Berman
Stuart Dixon
Company Number
16202851 (England and Wales)
Registered Office
16 Magdalen Road
Exeter
Devon
EX2 4SY
England
Accountants
Multiply Accountancy Limited
71-75 Shelton Street
London
WC2H 9JQ
Viridysbio Ltd
Statement of financial position
as at 30 June 2026
Cash at bank and in hand
308,406
Creditors: amounts falling due within one year
(6,531)
Net current assets
324,750
Called up share capital
19
Capital contribution reserve
964
Profit and loss account
(9,523)
Shareholders' funds
324,750
For the period ending 30 June 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 15 October 2026 and were signed on its behalf by
Stuart Dixon
Director
Company Registration No. 16202851
Viridysbio Ltd
Notes to the Accounts
for the period from 23 January 2025 to 30 June 2026
Viridysbio Ltd is a private company, limited by shares, registered in England and Wales, registration number 16202851. The registered office is 16 Magdalen Road, Exeter, Devon, EX2 4SY, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Government grants in relation to tangible fixed assets are credited to profit and loss account over the useful lives of the related assets, whereas those in relation to expenditure are credited when the expenditure is charged to profit and loss.
Amounts falling due within one year
Accrued income and prepayments
11,203
5
Creditors: amounts falling due within one year
2026
Taxes and social security
2,793
Viridysbio Ltd
Notes to the Accounts
for the period from 23 January 2025 to 30 June 2026
Allotted, called up and fully paid:
1,551,546 Ordinary shares of £0.00001 each
15.51
373,339 Ordinary A shares of £0.00001 each
3.73
Shares issued during the period:
1,551,546 Ordinary shares of £0.00001 each
15.51
373,339 Ordinary A shares of £0.00001 each
3.73
7
Transactions with related parties
During the period, Stuart Dixon, a director and shareholder, irrevocably waived £964 owed to him by the company. The amount has been recognised directly in equity as a capital contribution.
8
Post balance sheet events
On 7 July 2026, the company allotted 20,345 Ordinary A shares of £0.00001 each for cash consideration of £19,999.14.
9
Average number of employees
During the period the average number of employees was 1.